News and Press

Sofregen Medical Acquires SERI® Surgical Scaffold Product Line from Allergan

Company Expands Silk-Based Medical Technology Platform for Soft Tissue Repair Cambridge, Mass. — November 11, 2016 — Sofregen Medical Inc., an innovative company committed to advancing silk-based medical technologies to address soft tissue defects, today announced the acquisition of SERI® Surgical Scaffold product line from Allergan plc. Polaris Partners and other founding investors provided financing […]

Read More »

Sofregen Medical Bolsters Leadership Team and Board

Company Brings On Industry Veterans Chris White and Doug Sheldon to Move Silk-Based Products Platform Forward Cambridge, Mass. — November 9, 2016 — Sofregen Medical Inc. today announced major additions to its leadership team and Board of Directors. The company named Chris White as President and Chief Operating Officer and Doug Shelton as an independent […]

Read More »

Sofregen Medical Raises $6.2 Million in Series A Funding from Polaris Partners and Other Founding Investors

MEDFORD, Mass.–(BUSINESS WIRE)–Sofregen Medical Inc. (Sofregen), the company pioneering silk-based medical technologies to address soft tissue defects, today announced a $6.2 million Series A financing from Polaris Partners and other founding investors who previously seeded the company. Founded in 2014 to advance technology developed at Tufts University and the University of Pittsburgh, Sofregen has a […]

Read More »